LPL Financial
FLNA

LPL Financial’s Filana Therapeutics FLNA Stock Holding History

LPL Financial’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.8K Sell
40,172
-821
-2% -$1.17K ﹤0.01% 6033
2026
Q1 		$69.3K Sell
40,993
-2,434
-6% -$5.01K ﹤0.01% 5736
2025
Q4 		$86K Buy
43,427
+1,310
+3% +$4.19K ﹤0.01% 5636
2025
Q3 		$123K Buy
42,117
+23,747
+129% +$54.6K ﹤0.01% 5467
2025
Q2 		$33.3K Sell
18,370
-33,983
-65% -$60.5K ﹤0.01% 5417
2025
Q1 		$78.5K Buy
52,353
+5,525
+12% +$13.9K ﹤0.01% 5088
2024
Q4 		$111K Sell
46,828
-32,601
-41% -$573K ﹤0.01% 4972
2024
Q3 		$2.34M Buy
79,429
+17,321
+28% +$399K ﹤0.01% 2575
2024
Q2 		$767K Buy
62,108
+4,397
+8% +$92.7K ﹤0.01% 3497
2024
Q1 		$1.17M Buy
57,711
+1,689
+3% +$38.9K ﹤0.01% 3035
2023
Q4 		$1.26M Buy
56,022
+10,825
+24% +$229K ﹤0.01% 2847
2023
Q3 		$752K Buy
45,197
+623
+1% +$12.3K ﹤0.01% 3150
2023
Q2 		$1.09M Sell
44,574
-7,438
-14% -$179K ﹤0.01% 2770
2023
Q1 		$1.25M Buy
52,012
+9,716
+23% +$269K ﹤0.01% 2565
2022
Q4 		$1.25M Buy
42,296
+2,300
+6% +$82.7K ﹤0.01% 2467
2022
Q3 		$1.67M Sell
39,996
-4,021
-9% -$109K ﹤0.01% 2116
2022
Q2 		$1.24M Buy
44,017
+6,984
+19% +$176K ﹤0.01% 2411
2022
Q1 		$1.38M Sell
37,033
-1,682
-4% -$71.3K ﹤0.01% 2346
2021
Q4 		$1.69M Buy
38,715
+18,488
+91% +$970K ﹤0.01% 2215
2021
Q3 		$1.26M Buy
+20,227
New +$1.69M ﹤0.01% 2440

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

LPL Financial's FLNA Position: Q2 2026 in Review

LPL Financial reduced its Filana Therapeutics (FLNA) stake by 2% in Q2 2026, selling an estimated $1.17K and leaving 40,172 shares worth $47.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6033.

LPL Financial first reported a position in FLNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.34M in Q3 2024. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • LPL Financial held 40,172 shares of Filana Therapeutics worth $47.8K as of Q2 2026.
  • LPL Financial sold 821 Filana Therapeutics shares in Q2 2026, an estimated $1.17K.
  • Filana Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6033 holding.
  • LPL Financial first reported a position in Filana Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • LPL Financial's Filana Therapeutics position peaked at $2.34M in Q3 2024.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.